AC Immune SA has announced the appointment of Dr. Günther Staffler as the interim Executive Vice President, Development. Dr. Staffler, who joined the company in 2021, will oversee the development of active immunotherapies and clinical activities. Previously, he held senior roles at Affiris and other biotech companies in Vienna. Concurrently, Dr. Anke Post, the current Chief Medical Officer, will be leaving the company.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AC Immune Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000950103-25-007254), on June 11, 2025, and is solely responsible for the information contained therein.